On the mechanism of thrombin-induced angiogenesis: Inhibition of attachment of endothelial cells on basement membrane components

Angiogenesis

Volumn 1, Issue 2, 1997, Pages 192-200

  Tsopanoglou, Nikos E ^a   Maragoudakis, Michael E ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Angiogenesis; Basement membrane proteins; cAMP; Collagen type IV; Endothelial cell attachment; Protein kinase C; Thrombin

Indexed keywords

EID: 0003172925     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1018381822011     Document Type: Article

References (26)

1. Tsopanoglou NE, Pipili-Synetos E, Maragoudakis ME. Thrombin promotes angiogenesis by a mechanism independent of fibrin formation. Am J Physiol 1993; 264, C1302-C1307
2. Haralabopoulos G, Grant DS, Kleinman HK, Maragoudakis ME. Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo. Am J Physiol 1997; 273: C239-245.
3. Maragoudakis ME, Tsopanoglou NE, Sakkoula E, Pipili-Synetos E. On the mechanism of promotion of angiogenesis by thrombin. FASEB J 1995; 9, A587.
4. Silverstein RL, Nachman RL. Cancer and clotting - Trousseau's warning. N Engl J Med 1992; 327, 1163-1164.
5. Tapparelli C, Metternich R, Ehrhardt C, Cook NS. Synthetic low molecular weight thrombin inhibitor: molecular design and pharmacological profile. Trends Pharmac Sci 1993; 14, 366-376.
6. Garcia JGN, Aschner J, Malik AB. Regulation of thrombin-induced endothelial cell prostaglandin synthesis and barrier function. In: Berliner LJ (ed.), Thrombin: Structure and Function. New York: Plenum 1991: 397-430.
7. Rabiet MJ, Plantier JL, Rival Y, Genoux Y, Lampugnani MG, Dejana E. Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organisation. Arterioscler Thromb Vasc Biol 1996; 16, 488-496.
8. Kanthou C, Benzakour O. Cellular effects of thrombin and their signalling pathways. Cell Pharmacol 1995; 2, 293-302.
9. Zucker S, Conner C, DiMassmo BI, et al. Thrombin induces the activation of progelatinase A in vascular endothelial cells. Physiological regulation of angiogenesis. J Biol Chem 1996; 270, 23730-23738.
10. Papadimitriou E, Manolopoulos VG, Hayman GT, et al. Thrombin modulates vectorial secretion of extracellular matrix proteins in cultured endothelial cells. Am J Physiol 1997; 272, C1112-C1122.
11. Grand RJA, Turnell AS, Grabham PW. Cellular consequences of thrombin-receptor activation. Biochem J 1996; 313, 353-368.
12. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphological and immunological criteria. J Clin Invest 1973; 52, 2745-2756.
13. Tsopanoglou EN, Pipili-Synetos E, Maragoudakis ME. Protein kinase C involvement in the regulation of angiogenesis. J Vasc Res 1993; 30, 202-208.
14. Maragoudakis ME, Tsopanoglou NE, Haralabopoulos G, et al. Regulation of angiogenesis: the role of protein kinases, nitric oxide, thrombin, and basement membrane synthesis. In: Maragoudakis ME, Gullino P, Lelkes P (eds), Angiogenesis: Molecular Biology, Clinical Aspects. New York: Plenum Press 1994; 263, 125-134
15. Kobayashi E, Nakano H, Morimoto NM, Tamaoki Y. Caslphostin C (HCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1989; 159, 548-553.
16. Folkman J, Shing Y. Angiogenesis: minireview. J Biol Chem 1992; 267, 10931-10934.
17. Maragoudakis ME. Signal transduction pathways and the regulation of angiogenesis. In: Maragoudakis ME (ed.), Molecular, Cellular and Clinical Aspects of Angiogenesis. New York: Plenum 1996; 285, 115-123.
18. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1, 27-31.
19. Pauly RR, Passaniti A, Crow M, et al. Experimental models that mimic the differentiation and dedifferentiation of vascular cells. Circulation 1992; 86: III68-III73.
20. Lipfert L, Haimovich B, Schaller MD, Cobb BS, Parson JT, Brugge JS. Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets. J Cell Biol 1992; 119, 905-912.
21. Sakamoto T, Hinton DR, Sakamoto H, Gopalakrishna R, Ryan SJ, Donell PJ. Thrombin induced cytoskeletal change in cultured bovine corneal endothelial cells mediated via protein kinase C pathway. Curr Eye Res 1995; 14, 35-45.
22. Thurston G, Turner D. Thrombin-induced increase of F-actin in human umbilical vein endothelial cells. Microvasc Res 1994; 47, 1-20.
23. Bussolino F, Camussi G, Aglietta M, et al. Human endothelial cells are target for platelet-activating factor. J Immunol 1987; 139, 2439-2446.
24. Vu TKH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64, 1057-1068.
25. ++ but cAMP is the second messenger for morphological changes in rat megakaryocyte. Biochem Biophys Res Commun 1995; 211, 282-288.
26. Kanthou C, Kanse SM, Kakkar VV, Benzakour O. Involvement of pertussis toxin-sensitive and insensitive G-proteins in thrombin signalling on cultured vascular smooth muscle cells. Cell Signal 1996; 8, 59-66.